Rezolute, Inc. (RZLT)
2.28
+0.09
(+4.11%)
USD |
NASDAQ |
Dec 31, 09:48
Rezolute EPS Diluted (Quarterly): -0.1755 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Geron Corp. | -0.0276 |
| XOMA Royalty Corp. | 0.6991 |
| CorMedix, Inc. | 1.259 |
| Sarepta Therapeutics, Inc. | -1.795 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.15M |
| Total Expenses (Quarterly) | 18.15M |
| Enterprise Value | 52.33M |
| Earnings Yield | -40.75% |
| Normalized Earnings Yield | -40.75 |